UFP INDUSTRIES INC

For the period ended Dec 28, 2024. Filed Feb 26, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 26, 2025

UFPI$82.66+3.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Shareholders’ Equity


(in thousands of United States dollars, · · Controlling Interest Shareholders’ Equity · · ·
except share and per share data) · · · · · Additional · · · · · Accumulated Other · · · · · · · · ·
· · Common · · Paid-In · · Retained · · Comprehensive · · Noncontrolling · · · · · Temporary
· Stock · Capital · Earnings · Earnings · Interest (NCI) · Total · Equity
Balance on December 25, 2021	$61,902	$243,995	$1,678,121	$(5,405)	$37,956	$2,016,569	$—
Net earnings			692,651		12,210	704,861	103
Foreign currency translation adjustment				(1,841)	1,802	(39)	(630)
Unrealized loss on investments and other				(1,829)		(1,829)
Distributions to NCI					(12,024)	(12,024)
Contributions to NCI					538	538
NCI related to business combinations						—	(234)
Redeemable NCI					(7,641)	(7,641)	7,641
Cash dividends - $0.95 per share			(58,860)			(58,860)
Issuance of 44,012 shares under employee stock purchase plan (ESPP)	44	2,725				2,769
Issuance of 805,562 shares under stock grant programs	806	9,919	25			10,750
Issuance of 113,384 shares under deferred compensation plan	113	(113)				—
Repurchase of 1,246,616 shares	(1,247)		(94,527)			(95,774)
Expense associated with share-based compensation arrangements		27,987				27,987
Accrued expense under deferred compensation plans		9,516				9,516
Balance on December 31, 2022	$61,618	$294,029	$2,217,410	$(9,075)	$32,841	$2,596,823	$6,880
Net earnings (loss)			514,312		663	514,975	(518)
Foreign currency translation adjustment				9,762	4,267	14,029	388
Unrealized gain on investments and other				419		419
Other		(817)			930	113	43
Distributions to NCI					(7,355)	(7,355)
Purchase of remaining NCI of subsidiary		(1,210)			(917)	(2,127)
NCI related to business combinations						—	13,237
Cash dividends - $1.10 per share			(68,238)			(68,238)
Issuance of 32,944 shares under ESPP	33	2,717				2,750
Issuance of 820,591 shares under stock grant programs	821	14,485	22			15,328
Issuance of 124,145 shares under deferred compensation plan	124	(124)				—
Repurchase of 974,869 shares	(975)		(81,174)			(82,149)
Expense associated with share-based compensation arrangements		34,727				34,727
Accrued expense under deferred compensation plans		10,895				10,895
Balance on December 30, 2023	$61,621	$354,702	$2,582,332	$1,106	$30,429	$3,030,190	$20,030
Net earnings (loss)			414,560		5,413	419,973	(1,240)
Foreign currency translation adjustment				(16,428)	(3,441)	(19,869)	(122)
Unrealized loss on investments and other				11		11
Other		(242)				(242)
Distributions to NCI					(11,848)	(11,848)
Purchase of remaining NCI of subsidiary		8,400				8,400	(13,302)
Cash dividends - $1.32 per share			(80,782)			(80,782)
Issuance of 27,898 shares under ESPP	28	2,784				2,812
Issuance of 380,548 shares under stock grant programs	380	5,923	77			6,380
Issuance of 104,124 shares under deferred compensation plan	104	(104)				—
Repurchase of 1,409,266 shares	(1,409)	(17,686)	(140,907)			(160,002)
Expense associated with share-based compensation arrangements		37,938				37,938
Accrued expense under deferred compensation plans		11,664				11,664
Balance on December 28, 2024	$60,724	$403,379	$2,775,280	$(15,311)	$20,553	$3,244,625	$5,366

See notes to consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.